George W. Lloyd, EVP, Investments & GC at Royalty Pharma plc (RPRX), sold 174,078 shares at $42.01 ($7.3M) on 2021-07-07, disclosed to the SEC on 2021-07-08.
Open-market sale of $7.3M RPRX by EVP, Investments & GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.41 | 30,303 | $1.3M | 17.5% |
| 2 | $42.41 | 30,303 | $1.3M | 17.5% |
| 3 | $42.42 | 6,227 | $264K | 3.6% |
| 4 | $42.42 | 6,227 | $264K | 3.6% |
| 5 | $42.01 | 2,500 | $105K | 1.4% |
| 6 | $42.02 | 400 |
| $17K |
| 0.2% |
| 7 | $42.05 | 8,392 | $353K | 4.8% |
| 8 | $42.05 | 8,392 | $353K | 4.8% |
| 9 | $42.05 | 40,667 | $1.7M | 23.3% |
| 10 | $42.05 | 40,667 | $1.7M | 23.3% |
| Total | $42.20 avg | 174,078 | $7.3M | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |